INHSU go behind the scenes of three harm reduction organisations in Lisbon - CRESCER, GAT, and Ares do Pinhal, who provide vital harm reduction services such as Hepatitis C testing and treatment in safe and inclusive community-based settings.
INPUD present a best-practice toolkit, focused on key harm reduction interventions, based on interviews with twenty peer drug user activists and harm reduction specialists from a range of different countries.
Mainline review the current harm reduction programmes in Nepal from the perspective of women who inject drugs, and formulate recommendations to improve service delivery.
The EMCDDA shed light on emerging trends, challenges, and policy implications surrounding drug use in Europe up until the end of 2022, revealing high availability of substances and a greater need for harm reduction services.
EHRA publish their latest edition of CHECK magazine, focusing on the disproportionate levels of stigmatisation and discrimination that women who use drugs face as a result of existing gender inequalities and prohibitionist policies.
Victoria's first safe injecting room secures permanent status, marking a milestone in harm reduction efforts and sparking hope for a more compassionate and evidence-based approach towards people who inject drugs across Australia.
Safer consumption rooms led to reduced public injection, fewer health risks and lower crime, raising further questions about why they are not more widespread.
The HIV Legal Network argue for a human rights approach, focusing on evidence-based and culturally sensitive interventions that embrace Indigenous ways of knowing and doing.
INPUD, WHO and UNODC update WHO's Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care in relation to people who inject drugs.
CGHE and INHSU Prisons note that persons who are incarcerated experience the highest burdens of HCV globally and should therefore have the right to access HCV services, but they too often face systematic discrimination.
The Review Panel found that since its establishment in 2018, Richmond's supervised injecting facility has reduced overdose deaths and harm, and provided a gateway to health and social services, among other successes.
